Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Measuring relationship functioning in South African couples

South Africa Time — Thursday, January 09, 2020

Over the past decade, there has been increased focus on targeting couples in HIV prevention efforts, particularly in sub-Saharan Africa ...

View article...

LEGACY - for researchers

Top stories of the last 30 days

FDA slaps clinical hold on multiple Gilead HIV trials

South Africa Time — Wednesday, June 11, 2025

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...

HIV Long-Term Survivors Awareness Day 2025

South Africa Time — Friday, June 06, 2025

People diagnosed with HIV before the advent of highly active antiretroviral therapy, or HAART in 1996. They make up about 25% of all people living ... View article...

Initiation of HIV PrEP in Young Adults Rose in Recent Years

South Africa Time — Friday, June 06, 2025

Dispensing and initiation of HIV preexposure prophylaxis among young adults increased from 2016 through 2023. View article...

Nigeria : New HIV Drug May Exclude Vulnerable Populations

South Africa Time — Tuesday, June 24, 2025

The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...

HIV Prevention Has a Fantastic New Treatment

South Africa Time — Thursday, June 26, 2025

A new HIV prevention vaccine, Yezturgo Lenacapavir, is not a cure but taken twice a year, the treatment provides 99.9% protection. View article...

Domestic HIV Funding in the White House FY2026 Budget Request

South Africa Time — Friday, June 06, 2025

This brief provides an overview of the FY26 budget request for domestic HIV and compares it to funding levels in the FY25 continuing resolution. View article...

HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study

South Africa Time — Thursday, June 19, 2025

The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...

US FDA places clinical hold on Gilead trials testing HIV pill combination

South Africa Time — Wednesday, June 11, 2025

The U.S. Food and Drug Administration has placed a clinical hold on Gilead Sciences' trials testing a combination of two of its experimental HIV ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2025 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

HIV Prevention Has a Fantastic New Treatment

South Africa Time — Thursday, June 26, 2025

A new HIV prevention vaccine, Yezturgo Lenacapavir, is not a cure but taken twice a year, the treatment provides 99.9% protection. View article...

New HIV drug, heat wave, listeria, treating phone addiction and side effects from using social media

South Africa Time — Thursday, June 26, 2025

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest in HIV treatments, ... View article...

'Monumental' HIV shot could be coming to Canada

South Africa Time — Thursday, June 26, 2025

A twice-a-year shot to prevent HIV being dubbed a “wonder drug” by some could be coming to Canada as soon as next year, ... View article...

Flanders signs new two-year agreement with UNAIDS including €1.5 million contribution to ...

South Africa Time — Thursday, June 26, 2025

With 2.4 million people living with HIV in 2023, Mozambique has the second largest HIV epidemic after South Africa. A total of 2.1 million people ... View article...

Pneumocystis Pneumonia in a Non-HIV Patient With Advanced Liver Cirrhosis and No ...

South Africa Time — Tuesday, June 24, 2025

While its association with HIV is well known, there is a growing recognition of PCP in non- HIV patients, often linked to immunosuppressive therapy. View article...

Comparative Biomarker Analysis in HIV, PrEP, and Controls

South Africa Time — Tuesday, June 24, 2025

Elevated immune and neuronal injury markers in MSM with HIV and PrEP suggest lifestyle factors, beyond HIV , drive persistent inflammation. View article...

Nigeria : New HIV Drug May Exclude Vulnerable Populations

South Africa Time — Tuesday, June 24, 2025

The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...

Weight Regain After GLP-1 Discontinuation is Less Rapid in Real World: Hamlet Gasoyan, PhD

South Africa Time — Tuesday, June 24, 2025

The prevention of HIV could monumentally shift followong the FDA approval of lenacapavir on June 19, as the twice-yearly long-acting injectable form ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews